Citation: Hj. Van Der Woude et R. Aalbers, Compliance with inhaled glucocorticoids and concomitant use of long-actingbeta(2)-agonists, RESP MED, 95(5), 2001, pp. 404-407
Citation: Hj. Van Der Woude et R. Aalbers, Unaltered perception of dyspnoea during treatment with long-acting beta(2)-agonists, EUR RESP J, 18(2), 2001, pp. 269-271
Citation: Hj. Van Der Woude et al., Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta(2) agonists, THORAX, 56(7), 2001, pp. 529-535
Authors:
Vrugt, B
Wilson, S
Bron, A
Shute, J
Holgate, ST
Djukanovic, R
Aalbers, R
Citation: B. Vrugt et al., Low-dose methotrexate treatment in severe glucocorticoid-dependent asthma:effect on mucosal inflammation and in vitro sensitivity to glucocorticoidsof mitogen-induced T-cell proliferation, EUR RESP J, 15(3), 2000, pp. 478-485
Citation: Mj. Politiek et al., Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction, EUR RESP J, 13(5), 1999, pp. 988-992